European Health Authorities Investigate HPV Vaccines; the CBCD Reviews a Report

Rochester, NY -- (SBWire) -- 10/21/2015 --"Infected with the human papillomavirus (HPV)? The CBCD recommends talking to your doctor about a remedy discussed in several new clinical studies" - Greg Bennett, CBCD

European health regulators announced an investigation into the safety of all HPV vaccines after receiving many complaints regarding dangerous side effects. According to some of the families involved, "Previously healthy teenagers have suffered fits, extreme tiredness or even been left wheelchair-bound. Official figures show the HPV vaccination programme has drawn 8,228 reports of suspected side-effects since being launched in 2008, almost as much as all other routine jabs put together." (2) In beginning its safety review, the European Medicines Agency (EMA) said in a statement that "The current review will look at available data with a focus on rare reports of two conditions: complex regional pain syndrome (CRPS, a chronic pain condition affecting the limbs) and postural orthostatic tachycardia syndrome (POTS, a condition where the heart rate increases abnormally after sitting or standing up, causing symptoms such as dizziness and fainting, as well as headache, chest pain and weakness). (3)

Additionally, some families reported that "Parents are not being given enough information about potential side-effects of the vaccine … girls who fall ill after vaccination are not being taken seriously by GPs (General Physicians) when parents suggest the illness could be vaccine-related. Jackie Fletcher, of pressure group Jabs, said: 'Previously fit and healthy young girls have developed seizures or viral fatigue, some have lost the ability to walk. And years on, some have still not recovered.'" (4)

The Center for the Biology of Chronic Disease (CBCD) points out that while many governments have approved the HPV vaccine, still there is a minority of experts urging caution. For example, Dr. Uzi Beller, chief professor of obstetrics/gynecology at Shaare Zedek Medical Center in Israel, urged the medical community to be cautious in regards to HPV vaccination. "I want to see fundamental studies proving efficacy, and they do not exist." (See the Jerusalem Post, from September 21, 2013) (5)

The vaccines, Beller said, "were tested on mostly white women attending colleges and university - mostly from developed countries and healthy. The data were based on a relatively short term follow-up period. What is known does not yet justify widespread vaccination of healthy girls." (5) In addition, Dr. Beller said that "there is no evidence that prophylactic (preventative) vaccination against HPV types 16 and 18 reduces the incidence of cervical cancer." As the vaccine costs $100 to $360 for three doses in wealthy countries, it is completely out of the reach of developing countries, where an effective vaccine would be most urgently needed." (5)

The Jerusalem Post report concluded that "pediatricians are important advocates for preventive medicine, but they may know little about HPV infection and cervical and other HPV-related cancers. Obstetricians / Gynecologists know about HPV and cervical cancer prevention, but they often know little about vaccines and immunization delivery." (5)

Click to learn more about HPV symptoms.

"We believe doctors need facts. Many times, they're recommending vaccination to their patients because that's the party line of the National Health Service (NHS) at the moment." - Greg Bennett, CBCD

A recent post marketing clinical study published in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs on August 12, 2013 showed that the formula of at least one HPV remedy reduced HPV symptoms and was safe and effective. (6)

The formula was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the formula is effective against the HPV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, "individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with (the formula)." (6) The study authors also wrote that "we observed a statistically significant decrease in the severity, duration, and frequency of symptoms." (6)

Doctors can view the papers on that formula here:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.VIBA_NKUf90

Are there other treatments or remedies available against the HPV?

"There are no drugs approved against the HPV. Current treatments include procedures, such as cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). These procedures use liquid nitrogen, a surgical knife (scalpel), a carbon dioxide (CO2) laser, or electrical current to remove the abnormal growths caused by the HPV. These growths include cells that harbor the active virus (this is before the HPV has caused cancer). The procedures do not target cells with the latent virus. Since they do not remove the latent virus, these procedures only produce a temporary remission." (6)

In light of this evidence, the CBCD recommends that HSV infected individuals talk to their doctors about the medical studies mentioned above.

Reference:

(1) European Medicines Agency - Human papillomavirus vaccines - "EMA to further clarify safety profile of human papillomavirus (HPV) vaccines" Published July 13, 2015

(2) Spencer, B "Safety probe into cervical cancer jab: Families win action over side-effects" Published July 13, 2015. DailyMail.co.uk

(3) Gever, J. "EMA to Probe HPV Vaccination Safety" Published July 13, 2015 - MedPage Today

(4) Macrae, F. "Tens of thousands of teenage girls believed to have fallen ill with debilitating illnesses after routine HPV cervical cancer jab." Last updated June 1, 2015. Mail Online

(5) Siegel-Itzkovich, J. "HPV: To vaccinate or not to vaccinate." Published September 21, 2013.

http://www.jpost.com/Health-and-Science/HPV-To-vaccinate-or-not-to-vaccinate-326711

(6) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8